Delivering timely service and evidence-informed resources to people in BC and the Yukon facing cancer and those involved in oncology care or research.
"Clinical and preclinical exploration of gene and cellular immunotherapy have seen rapid growth and interest with the development and approval of five Chimeric Antigen Receptor T-cell (CAR-T) products for lymphoma and myeloma and one Bispecific T-Cell Engager (BiTE) for acute lymphoblastic leukemia…
Myelodysplastic syndromes/acute myeloid leukemia : new therapeutic targets; Mechanisms of disease and novel therapy for sickle cell vasculopathy; Hodgkin lymphoma : clinical challenges and new approaches; B-cell lymphomas : new molecular targets; Chronic lymphocytic leukemia : novel therapies; Anem…
c.1 BC Cancer Agency VAN Library AV Room | Available |